Home » Stocks » Aspira Women's Health

Aspira Women's Health, Inc. (AWH)

Stock Price: $4.05 USD 0.34 (9.16%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 394.38M
Revenue (ttm) 4.96M
Net Income (ttm) -15.23M
Shares Out 100.19M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $4.05
Previous Close $3.71
Change ($) 0.34
Change (%) 9.16%
Day's Open 3.77
Day's Range 3.74 - 4.34
Day's Volume 976,067
52-Week Range 0.35 - 5.78

More Stats

Market Cap 394.38M
Enterprise Value 387.49M
Earnings Date (est) Aug 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 100.19M
Float 52.24M
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share -0.14
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.28M
Short Ratio 4.21
Short % of Float 4.63%
Beta 3.47
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 79.59
PB Ratio 87.11
Revenue 4.96M
Operating Income -15.36M
Net Income -15.23M
Free Cash Flow -13.47M
Net Cash 6.89M
Net Cash / Share 0.07
Gross Margin 24.12%
Operating Margin -309.97%
Profit Margin -307.30%
FCF Margin -271.77%
ROA -103.18%
ROE -340.69%
ROIC 3,863.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$1.00*
Low
1.00
Current: 4.05
High
1.00
Target: 1.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue4.543.053.122.642.182.522.572.091.921.18
Revenue Growth48.64%-2.18%18.13%21.36%-13.65%-1.75%22.54%8.89%63.66%-
Gross Profit1.20-0.090.21-0.06-0.131.292.401.961.791.09
Operating Income-15.28-11.33-10.44-14.95-19.25-19.21-8.86-8.62-17.74-16.28
Net Income-15.24-11.37-10.50-14.97-19.12-19.21-8.82-7.15-17.79-19.03
Shares Outstanding86.6070.0956.9452.2047.1236.0820.9315.0114.2510.40
Earnings Per Share-0.18-0.16-0.20-0.29-0.41-0.53-0.42-0.48-1.25-1.83
Operating Cash Flow-12.97-9.37-8.13-13.96-18.37-16.81-8.22-10.40-15.58-20.94
Capital Expenditures-0.13-0.11-0.06-1.26-1.06-0.26-0.32-0.01-0.10-0.18
Free Cash Flow-13.10-9.48-8.19-15.22-19.42-17.07-8.55-10.41-15.68-21.11
Cash & Equivalents11.709.365.545.2418.6422.9729.508.0122.4822.91
Total Debt1.291.481.671.85-1.111.111.117.0012.00
Net Cash / Debt10.417.883.873.3918.6421.8628.406.9015.4810.91
Assets13.8311.417.508.0220.9624.1730.648.6323.1124.04
Liabilities5.094.264.094.263.414.923.873.9712.7519.42
Book Value8.747.153.413.7617.5519.2626.774.6710.364.62
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Aspira Women's Health, Inc.
Country United States
Employees 52
CEO Valerie Barber Palmieri

Stock Information

Ticker Symbol AWH
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: AWH

Description

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company provides sells OVA1, Overa, and Ova1PLUS risk of malignancy tests for ovarian cancer. It also offers ASPiRA GenetiX, a genetic test for specific women's health diseases. In addition, the company owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, it is developing diagnostic algorithms, as well as a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. The company serves physicians, physician office laboratories, and hospital laboratories. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was founded in 1993 and is headquartered in Austin, Texas.